Severe cholestasis due to adalimumab in a Crohn’s disease patient

Elevation of liver biochemistry has been reported with anti-tumor necrosis factor agents, but overt liver failure rarely reported. Autoimmune hepatitis has been more commonly reported with infliximab than adalimumab (ADA). Our case, however, describes the first reported case of ADA-associated severe...

Full description

Saved in:
Bibliographic Details
Main Authors: Kim, Edward, Bressler, Brian, Schaeffer, David F, Yoshida, Eric M
Format: Artigo
Language:Inglês
Published: Baishideng Publishing Group Co., Limited 2013
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3812463/
https://ncbi.nlm.nih.gov/pubmed/24179620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v5.i10.592
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items